Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
about
Probiotics in infants for prevention of allergic disease and food hypersensitivityThe microbiome of the lungIsolation of bifidobacteria from breast milk and assessment of the bifidobacterial population by PCR-denaturing gradient gel electrophoresis and quantitative real-time PCRModulation of Immune Functions by FoodsThe Microbiota and Health Promoting Characteristics of the Fermented Beverage KefirTight junctions, intestinal permeability, and autoimmunity: celiac disease and type 1 diabetes paradigmsA randomized prospective double blind controlled trial on effects of long-term consumption of fermented milk containing Lactobacillus casei in pre-school children with allergic asthma and/or rhinitisHuman gut microbiota and healthy aging: Recent developments and future prospectiveBarcoded pyrosequencing reveals that consumption of galactooligosaccharides results in a highly specific bifidogenic response in humansAlignment-independent comparisons of human gastrointestinal tract microbial communities in a multidimensional 16S rRNA gene evolutionary space.Early intestinal Bacteroides fragilis colonisation and development of asthmaDose-response study of probiotic bacteria Bifidobacterium animalis subsp lactis BB-12 and Lactobacillus paracasei subsp paracasei CRL-341 in healthy young adults.Bacterial metabolism and health-related effects of galacto-oligosaccharides and other prebiotics.The role of the bacterial microbiome in lung diseaseQuantitative real-time PCR assays to identify and quantify fecal Bifidobacterium species in infants receiving a prebiotic infant formulaDenaturing gradient gel electrophoresis of neonatal intestinal microbiota in relation to the development of asthma.Temporal development of the infant gut microbiota in immunoglobulin E-sensitized and nonsensitized children determined by the GA-map infant arrayProduction of conjugated linoleic and conjugated α-linolenic acid in a reconstituted skim milk-based medium by bifidobacterial strains isolated from human breast milk.Aberrant structures of fecal bacterial community in allergic infants profiled by 16S rRNA gene pyrosequencing.Atopic dermatitis and the 'hygiene hypothesis': too clean to be true?Bifidobacterium breve with α-linolenic acid and linoleic acid alters fatty acid metabolism in the maternal separation model of irritable bowel syndromeIs the effect of probiotics on atopic dermatitis confined to food sensitized children?Effect of a synbiotic yogurt on levels of fecal bifidobacteria, clostridia, and enterobacteria.Synbiotic consumption changes the metabolism and composition of the gut microbiota in older people and modifies inflammatory processes: a randomised, double-blind, placebo-controlled crossover study.Toward the comprehensive understanding of the gut ecosystem via metabolomics-based integrated omics approach.Differences in Gut Microbiota Between Atopic and Healthy Children.Long Term Development of Gut Microbiota Composition in Atopic Children: Impact of ProbioticsThe influence of the young microbiome on inflammatory diseases--Lessons from animal studies.Hydrolysed inulin alleviates the azoxymethane-induced preneoplastic aberrant crypt foci by altering selected intestinal microbiota in Sprague-Dawley rats.Effect of probiotic bacteria on induction and maintenance of oral tolerance to beta-lactoglobulin in gnotobiotic mice.Impact of intestinal microbiota on intestinal luminal metabolome.Lessons from the genomes of bifidobacteria.Mucosal immunity and allergic responses: lack of regulation and/or lack of microbial stimulation?Diet-induced dysbiosis of the intestinal microbiota and the effects on immunity and disease.Colonic Absorption of Low-Molecular-Weight Metabolites Influenced by the Intestinal Microbiome: A Pilot StudyThe 'microflora hypothesis' of allergic diseases.Use of probiotics in pediatrics: rationale, mechanisms of action, and practical aspects.Distribution of different species of the Bacteroides fragilis group in individuals with Japanese cedar pollinosisProbiotics in clinical practice: an overview.Probiotics and atopic dermatitis in children.
P2860
Q24243561-EF76722F-92C6-4D59-BA62-2A591DD235F9Q24602074-B5DEFCD0-987F-436E-9CFD-3453CC3E3B07Q24652398-B800FEE3-2D14-4FE2-80B3-C4B6BACC6AECQ24808820-36885379-5F0B-4E8F-B6CB-475102AE7818Q26747430-CE40F65B-7242-41F8-A346-5A50CE22B985Q28249095-606E32EB-BDAE-48BC-9922-9B62A53C51A3Q28307749-EDFA17B9-0272-4943-8EE3-340C40611174Q28586306-2A4AD1C5-B006-4615-B710-D38BB1D0B76FQ28744560-76BF66C3-24EA-4A1B-BE3C-65BDA4ABBBA5Q33276818-FD9E1C1F-5A33-4424-9AB8-7A1DA92F0FBFQ33372440-0647109D-70DB-4F2C-B561-B9B2DB02A7F2Q33435312-020BDB80-2197-45BF-AD9B-6EDA3D221CCBQ33439062-97B394DA-FFB4-44AA-B7E2-0B1AC6DA07FDQ33554623-76FA539F-3E39-482C-AD62-0FFB1A425B9FQ33769746-B001F92F-1365-4183-986C-F697CA684EE3Q33866445-93BBC965-96C0-4CB0-8E95-DFFFB5AD3340Q33926628-3D97D736-F8CE-4A61-B774-6B4561393FBFQ33943738-191181B4-C038-48D6-AE23-81F21385FB04Q34059100-1CB2E430-DA31-483C-B179-73347023B3A8Q34396961-D16700E5-244D-4CE6-90C3-167958EF5E64Q34489621-C514996C-8F10-4DD2-98E3-C40FF80B526FQ34566921-FD704C51-E73D-4B95-B024-99DE7EB17A4FQ34633825-BE7C27B4-C14B-40F3-8011-DC27AA024D9BQ34955829-160F80CC-A9EE-40CC-96F4-54C8B8FFF2FCQ35359043-0CBC0FE3-89E1-47BD-81F2-B7331D65C21EQ35600495-3B56275E-8BFC-40EE-8810-4C80F8C588FDQ35778412-AA32D576-BBA9-459E-A45B-B352478EEF2BQ35867975-70CFB843-B40D-43C4-B89D-AD49A3D155A1Q35900047-1D83F703-B9DC-4EC5-BF96-2275BE22E51FQ35923434-AB21BE5B-A951-4BCD-BCC0-B977947CCC2AQ36050216-083377F7-10D9-4BBE-8946-534B21253A87Q36153923-53E77EB9-9945-47F6-AD0D-FD8DCA4B774FQ36209726-4A014AAC-29FD-4D57-8081-D2FD2F437ABCQ36250322-3ABBBF77-A00F-4369-B604-EC09275ECAF4Q36259668-91833F0C-AD4A-48DA-8C4E-8DF600779A24Q36360555-00B36D5C-E986-492C-9C70-E7D20578150FQ36824470-586A5E23-287F-4BA4-A48A-8E58C937B5EDQ36958171-057F6AF1-D020-47EA-8E4E-665501E420C6Q37071265-1B89B1F2-BE58-4430-9726-EC17A653AF2EQ37148768-8C098E75-0DEA-44E4-8911-EBEBF1ECAC67
P2860
Aberrant composition of gut microbiota of allergic infants: a target of bifidobacterial therapy at weaning?
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@en
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@nl
type
label
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@en
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@nl
prefLabel
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@en
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@nl
P2093
P2860
P356
P1433
P1476
Aberrant composition of gut mi ...... obacterial therapy at weaning?
@en
P2093
E Isolauri
P V Kirjavainen
S J Salminen
P2860
P356
10.1136/GUT.51.1.51
P407
P577
2002-07-01T00:00:00Z